BioLineRx Ltd (BLRX) — Cash Flow Quality Index

Latest as of March 2025: -0.51x

BioLineRx Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of $-2.59 Million is below net income of $5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BioLineRx Ltd (BLRX) long-term investment share to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.51x
Operating CF / Net Income

Operating Cash Flow

$-2.59 Million
USD

Net Income

$5.13 Million
USD

Data as of

Mar 2025
Most recent filing

BioLineRx Ltd Cash Flow Quality Index (2010–2010)

Historical Cash Flow Quality Index for BioLineRx Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BioLineRx Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for BioLineRx Ltd (2010–2010)

Year-by-year earnings quality comparison for BioLineRx Ltd. For live market cap and the full company financial profile, see BioLineRx Ltd stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2010 5.47x $11.46 Million $2.10 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.